Synthesis and evaluation of oxime derivatives as modulators for amyloid beta-induced mitochondrial dysfunction

Young Seub Kim, Sun Hwa Jung, Beoung Geon Park, Min Kyung Ko, Hyun Seo Jang, Kihang Choi, Ja-Hyun Baik, Jiyoun Lee, Jae Kyun Lee, Ae Nim Pae, Yong Seo Cho, Sun Joon Min

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Starting from quinuclidinyl oxime 1 identified by preliminary screening, a series of azacycles-containing oxime derivatives was synthesized. Their mPTP blocking activities were evaluated by a JC-1 assay, measuring the change of mitochondrial membrane potential. The inhibitory activity of nine compounds against amyloid beta-induced mPTP opening was comparable or even superior to that of piracetam. Among them, 12d effectively maintained mitochondrial function and cell viabilities on the ATP assay, the MTT assay, and the ROS assay. In addition, it exhibited favorable in vitro stability and pharmacokinetic characteristics, which hold a promise for further development of AD therapeutics.

Original languageEnglish
Pages (from-to)71-83
Number of pages13
JournalEuropean Journal of Medicinal Chemistry
Volume62
DOIs
Publication statusPublished - 2013 Apr 1

Fingerprint

Oximes
Amyloid
Modulators
Assays
Piracetam
Derivatives
Mitochondrial Membrane Potential
Cell Survival
Pharmacokinetics
Adenosine Triphosphate
Screening
Cells
Membranes
Therapeutics
5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine
In Vitro Techniques

Keywords

  • Alzheimer's disease
  • Amyloid beta
  • Mitochondrial permeability transition pore (mPTP)
  • Oxime derivatives
  • Pharmacokinetics

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

Synthesis and evaluation of oxime derivatives as modulators for amyloid beta-induced mitochondrial dysfunction. / Kim, Young Seub; Jung, Sun Hwa; Park, Beoung Geon; Ko, Min Kyung; Jang, Hyun Seo; Choi, Kihang; Baik, Ja-Hyun; Lee, Jiyoun; Lee, Jae Kyun; Pae, Ae Nim; Cho, Yong Seo; Min, Sun Joon.

In: European Journal of Medicinal Chemistry, Vol. 62, 01.04.2013, p. 71-83.

Research output: Contribution to journalArticle

Kim, Young Seub ; Jung, Sun Hwa ; Park, Beoung Geon ; Ko, Min Kyung ; Jang, Hyun Seo ; Choi, Kihang ; Baik, Ja-Hyun ; Lee, Jiyoun ; Lee, Jae Kyun ; Pae, Ae Nim ; Cho, Yong Seo ; Min, Sun Joon. / Synthesis and evaluation of oxime derivatives as modulators for amyloid beta-induced mitochondrial dysfunction. In: European Journal of Medicinal Chemistry. 2013 ; Vol. 62. pp. 71-83.
@article{c75075b9efa64d8595a9d979f1afefed,
title = "Synthesis and evaluation of oxime derivatives as modulators for amyloid beta-induced mitochondrial dysfunction",
abstract = "Starting from quinuclidinyl oxime 1 identified by preliminary screening, a series of azacycles-containing oxime derivatives was synthesized. Their mPTP blocking activities were evaluated by a JC-1 assay, measuring the change of mitochondrial membrane potential. The inhibitory activity of nine compounds against amyloid beta-induced mPTP opening was comparable or even superior to that of piracetam. Among them, 12d effectively maintained mitochondrial function and cell viabilities on the ATP assay, the MTT assay, and the ROS assay. In addition, it exhibited favorable in vitro stability and pharmacokinetic characteristics, which hold a promise for further development of AD therapeutics.",
keywords = "Alzheimer's disease, Amyloid beta, Mitochondrial permeability transition pore (mPTP), Oxime derivatives, Pharmacokinetics",
author = "Kim, {Young Seub} and Jung, {Sun Hwa} and Park, {Beoung Geon} and Ko, {Min Kyung} and Jang, {Hyun Seo} and Kihang Choi and Ja-Hyun Baik and Jiyoun Lee and Lee, {Jae Kyun} and Pae, {Ae Nim} and Cho, {Yong Seo} and Min, {Sun Joon}",
year = "2013",
month = "4",
day = "1",
doi = "10.1016/j.ejmech.2012.12.033",
language = "English",
volume = "62",
pages = "71--83",
journal = "European Journal of Medicinal Chemistry",
issn = "0223-5234",
publisher = "Elsevier Masson SAS",

}

TY - JOUR

T1 - Synthesis and evaluation of oxime derivatives as modulators for amyloid beta-induced mitochondrial dysfunction

AU - Kim, Young Seub

AU - Jung, Sun Hwa

AU - Park, Beoung Geon

AU - Ko, Min Kyung

AU - Jang, Hyun Seo

AU - Choi, Kihang

AU - Baik, Ja-Hyun

AU - Lee, Jiyoun

AU - Lee, Jae Kyun

AU - Pae, Ae Nim

AU - Cho, Yong Seo

AU - Min, Sun Joon

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Starting from quinuclidinyl oxime 1 identified by preliminary screening, a series of azacycles-containing oxime derivatives was synthesized. Their mPTP blocking activities were evaluated by a JC-1 assay, measuring the change of mitochondrial membrane potential. The inhibitory activity of nine compounds against amyloid beta-induced mPTP opening was comparable or even superior to that of piracetam. Among them, 12d effectively maintained mitochondrial function and cell viabilities on the ATP assay, the MTT assay, and the ROS assay. In addition, it exhibited favorable in vitro stability and pharmacokinetic characteristics, which hold a promise for further development of AD therapeutics.

AB - Starting from quinuclidinyl oxime 1 identified by preliminary screening, a series of azacycles-containing oxime derivatives was synthesized. Their mPTP blocking activities were evaluated by a JC-1 assay, measuring the change of mitochondrial membrane potential. The inhibitory activity of nine compounds against amyloid beta-induced mPTP opening was comparable or even superior to that of piracetam. Among them, 12d effectively maintained mitochondrial function and cell viabilities on the ATP assay, the MTT assay, and the ROS assay. In addition, it exhibited favorable in vitro stability and pharmacokinetic characteristics, which hold a promise for further development of AD therapeutics.

KW - Alzheimer's disease

KW - Amyloid beta

KW - Mitochondrial permeability transition pore (mPTP)

KW - Oxime derivatives

KW - Pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=84872676241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872676241&partnerID=8YFLogxK

U2 - 10.1016/j.ejmech.2012.12.033

DO - 10.1016/j.ejmech.2012.12.033

M3 - Article

C2 - 23353734

AN - SCOPUS:84872676241

VL - 62

SP - 71

EP - 83

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

SN - 0223-5234

ER -